LCMRX | VMGIX | LCMRX / VMGIX | |
Total Expense Ratio | 1.45 | 0.19 | 763% |
Annual Report Gross Expense Ratio | 1.57 | 0.19 | 826% |
Fund Existence | 12 years | 19 years | - |
Gain YTD | 7.054 | 13.334 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 305M | 32.3B | 1% |
Annual Yield % from dividends | 0.00 | 0.51 | - |
Returns for 1 year | 22.70 | 25.14 | 90% |
Returns for 3 years | 54.08 | 55.52 | 97% |
Returns for 5 years | 32.18 | 62.58 | 51% |
Returns for 10 years | 87.23 | 184.28 | 47% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 143.12 | 2.77 | +1.97% |
iShares Biotechnology ETF | |||
VGM | 9.71 | 0.16 | +1.68% |
Invesco Trust Investment Grade Municipals | |||
IPB | 25.72 | 0.02 | +0.06% |
Merrill Lynch Depositor | |||
UJUN | 36.36 | -0.03 | -0.08% |
Innovator U.S. Equity Ultra BffrETF™-Jun | |||
CANQ | 29.41 | -0.04 | -0.15% |
Calamos Nasdaq® Equity & Income ETF |